BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murray A, Nguyen TM, Parker CE, Feagan BG, MacDonald JK. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2020;8:CD000544. [PMID: 32856298 DOI: 10.1002/14651858.CD000544.pub5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Liu H, Zhang Q, Luo Y, Wu L, Zhong Y, Tang Z, Pu Y, Lu C, Yin G, Xie Q. Cinacalcet Targets the Neurokinin-1 Receptor and Inhibits PKCδ/ERK/P65 Signaling to Alleviate Dextran Sulfate Sodium-Induced Colitis. Front Pharmacol 2021;12:735194. [PMID: 34880751 DOI: 10.3389/fphar.2021.735194] [Reference Citation Analysis]
2 Yadav V, Mai Y, McCoubrey LE, Wada Y, Tomioka M, Kawata S, Charde S, Basit AW. 5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease. Biomedicines 2021;9:578. [PMID: 34065300 DOI: 10.3390/biomedicines9050578] [Reference Citation Analysis]
3 Jin M, Li S, Wu Y, Li D, Han Y. Construction of Chitosan/Alginate Nano-Drug Delivery System for Improving Dextran Sodium Sulfate-Induced Colitis in Mice. Nanomaterials (Basel) 2021;11:1884. [PMID: 34443715 DOI: 10.3390/nano11081884] [Reference Citation Analysis]
4 Rong Y, Hong G, Zhu N, Liu Y, Jiang Y, Liu T. Photodynamic Therapy of Novel Photosensitizer Ameliorates TNBS-Induced Ulcerative Colitis via Inhibition of AOC1. Front Pharmacol 2021;12:746725. [PMID: 34744725 DOI: 10.3389/fphar.2021.746725] [Reference Citation Analysis]
5 Noda M, Danshiitsoodol N, Kanno K, Uchida T, Sugiyama M. The Exopolysaccharide Produced by Lactobacillus paracasei IJH-SONE68 Prevents and Ameliorates Inflammatory Responses in DSS-Induced Ulcerative Colitis. Microorganisms 2021;9:2243. [PMID: 34835369 DOI: 10.3390/microorganisms9112243] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tripathi K, Dong J, Mishkin BF, Feuerstein JD. Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis. Clin Exp Gastroenterol 2021;14:343-51. [PMID: 34511961 DOI: 10.2147/CEG.S237653] [Reference Citation Analysis]
7 Fossmark R, Olaisen M, Martinsen TC, Melberg HO. Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort study. Therap Adv Gastroenterol 2021;14:17562848211021760. [PMID: 34262610 DOI: 10.1177/17562848211021760] [Reference Citation Analysis]